Microbial Regulation of IgE Production in Early Life
Poster Feb 21, 2015
Ana B Blazquez, Jeremiah J Faith, Hugh A Sampson, M Cecilia Berin
Rationale: Changes in gastrointestinal microbiota have been suggested to drive the increasing prevalence of food allergy. Our aim was to determine the impact of mouse and human intestinal microbiota on modulation of allergic parameters including IgE.
Methods: C57BL/6 mice were treated with antibiotics (ABX) for 4 weeks. Germ-free (GF) mice were colonized with fecal microbiota from a healthy pediatric donor. Total serum IgE, IgA, and IgG were analyzed by ELISA, blood eosinophils and basophils by flow cytometry, and cytokine expression in Peyer’s patches (PP) by qPCR.
Results: ABX treatment immediately after weaning induced a significant increase in total serum IgE (45.6±10.5 ng/ml (ABX) vs 12.2±2.8 ng/ml (control), and surface IgE on basophils (4377±1371 MFI (ABX) vs 1139±666 (Control)). The levels of other isotypes were unchanged. Circulating eosinophils were also significantly increased (2.37±0.83% (ABX) vs 1.42±0.25% (control)). IL-4 was significantly upregulated in the PP after ABX-treatment of young mice. Susceptibility of IgE and eosinophils to modulation by ABX was rapidly lost, and was not observed in 5 week old mice. GF-mice had progressively increasing levels of IgE with age (187±75 ng/ml at 8 weeks and 623±131 ng/ml at 12 weeks). Colonization with human microbiota at 4 or 8 weeks of age significantly suppressed IgE as measured 4 weeks later (77.75±38.60 and 205.5±148.3 ng/ml).
Conclusions: In mice there is an early-life window of antibiotic exposure that leads to elevated IgE and other allergic parameters. Transfer of human microbiota to germ-free mice suppresses IgE and offers a unique model system to study regulatory activity of human microbiota.
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE
This abstract discusses three cases of pediatric heart transplant patients who suffered from parvovirus (B19) infection. Of these patients, two ( B & C) responded well to standard intravenous Ig therapy. Patient A however, did not respond to standard treatment and was begun on subcutaneous Ig, which effectively diminished his viral load. Thus, subcutaneous Ig infusions might serve as a second line treatment for transplant patients with parvovirus who do not respond well to the standard approach.READ MORE